Date: 2015-03-17
Type of information: Collaboration agreement
Compound:
Company: Broad Institute of MIT and Harvard (USA - MA) Calico (USA - CA)
Therapeutic area:
Type agreement: R&D collaboration
Action mechanism:
Disease: age-related diseases
Details: * On March 17th, 2015, the Broad Institute of MIT and Harvard has entered into a partnership with Calico around the biology and genetics of aging and early-stage drug discovery. The partnership will support several efforts at the Broad to advance the understanding of age-related diseases and to propel the translation of these findings into new therapeutics.
Calico is the Google-backed life sciences company led by Arthur D. Levinson, Ph.D. (former Chairman and CEO of Genentech) and Hal V. Barron, M.D. (former Executive Vice President and Chief Medical Officer of Genentech). As part of the collaboration, the Broad Institute will pursue shared goals with Calico by leveraging the Institute\'s deep genetics and biology expertise and novel drug-discovery tools.
Financial terms:
Latest news:
